Immuron (IMRN) EBIAT (2016 - 2024)
Immuron has reported EBIAT over the past 9 years, most recently at $1660259165.7 billion for Q4 2024.
- For Q4 2024, EBIAT rose 1.2301662815363432e+16% year-over-year to $1660259165.7 billion; the TTM value through Dec 2024 reached $1660259165.7 billion, up 36079587289443.56%, while the annual FY2025 figure was -$3.4 million, 25.69% up from the prior year.
- EBIAT for Q4 2024 was $1660259165.7 billion at Immuron, up from -$13496.2 in the prior quarter.
- Over five years, EBIAT peaked at $1660259165.7 billion in Q4 2024 and troughed at -$6.5 million in Q2 2021.
- A 5-year average of $184473240.6 billion and a median of -$57387.7 in 2020 define the central range for EBIAT.
- Biggest five-year swings in EBIAT: plummeted 277.25% in 2020 and later skyrocketed 1.2301662815363432e+16% in 2024.
- Year by year, EBIAT stood at -$57387.7 in 2020, then skyrocketed by 77.0% to -$13196.5 in 2021, then grew by 1.5% to -$12998.4 in 2022, then dropped by 3.83% to -$13496.2 in 2023, then skyrocketed by 1.2301662815363436e+16% to $1660259165.7 billion in 2024.
- Business Quant data shows EBIAT for IMRN at $1660259165.7 billion in Q4 2024, -$13496.2 in Q4 2023, and -$2.5 million in Q2 2023.